3 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Three-Dimensional Conformal Radiation Therapy: new trials by email Literature Review of Three-Dimensional Conformal Radiation Therapy trials Research Report on Three-Dimensional Conformal Radiation Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer Three-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy - Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma | Phase 2 / Phase 3 | Completed | NRG Oncology | 418 | 2015-12-22 | 2026-07-10 |
| Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer cisplatin, 5-fluorouracil, Mitomycin - Bladder Cancer | Phase 2 | Completed | Radiation Therapy Oncology Group | 37 | 2009-11-01 | 2024-09-19 |
| Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer carboplatin, paclitaxel, three-dimensional conformal radiation therapy - Lung Cancer | Phase 1 / Phase 2 | Completed | Radiation Therapy Oncology Group | 63 | 2001-07-01 | 2017-12-22 |
Adenocarcinoma of Lung (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Urinary Bladder Neoplasms (1)
Radiation Therapy Oncology Group (2) · NRG Oncology (1)
United States (3) · Canada (2)
Jeffrey Bradley, MD (1) · Vinai Gondi (1) · William U. Shipley, MD, FACR (1)
PMID 20368547, PMID 20457350, PMID 34632876, PMID 39226514, PMID 40789106
UG1CA189867 (1)